Skip to content

Subjective Evaluation of a Commercially Marketed Contact Lens Amongst a Subset of the Contact Lens Wearing Population

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01007916
Enrollment
50
Registered
2009-11-05
Start date
2009-10-31
Completion date
2010-01-31
Last updated
2012-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Brief summary

The purpose of this study is to compare the performance of commercially marketed contact lenses to habitual contact lenses in a selected segment of the contact lens wearing population.

Interventions

Commercially marketed, silicone hydrogel, spherical contact lens having a recommended replacement schedule of monthly.

Habitual soft spherical contact lens having a recommended replacement schedule of 2 weeks or monthly.

Sponsors

CIBA VISION
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Habitual spherical soft contact lens wearer who wears a contact lens with a recommended replacement schedule of 2 weeks or monthly. * Wears lenses at least 5 days per week and at least 12 hours per day. * Removes contact lenses daily or, if prescribed by their regular eye care practitioner, sleeps overnight in contact lenses no more than 6 consecutive nights. * Reports 2 or fewer common lens-related symptoms with current contact lenses with a frequency of frequently or always. * Able to achieve distance visual acuity of at least 20/40 in each eye at the dispense of each pair of study lenses. * Has acceptable or optimal fit for each eye at the dispense of each pair of study lenses. * Other protocol-defined inclusion/

Exclusion criteria

may apply.

Design outcomes

Primary

MeasureTime frameDescription
Comfort Upon Insertion4 weeks of wearComfort upon insertion, as interpreted by the participant, was recorded on a questionnaire by the participant using a 10-point scale, with 1 being poor and 10 being excellent. Comfort upon insertion was assessed as a single, retrospective evaluation of 4-weeks' wear time.

Participant flow

Pre-assignment details

One participant was enrolled but not dispensed due to failing inclusion/exclusion criteria. This participant is included in the Actual Enrollment calculation, but not Participant Flow or Baseline Characteristics calculations.

Participants by arm

ArmCount
Overall Study
This reporting group includes all enrolled and dispensed subjects
49
Total49

Withdrawals & dropouts

PeriodReasonFG000FG001
Period 1, 4 Weeks of WearFailed inclusion/exclusion10
Period 2, 4 Weeks of WearRelocation10

Baseline characteristics

CharacteristicOverall Study
Age Continuous30.4 years
STANDARD_DEVIATION 10.2
Sex: Female, Male
Female
34 Participants
Sex: Female, Male
Male
15 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 490 / 48
serious
Total, serious adverse events
0 / 490 / 48

Outcome results

Primary

Comfort Upon Insertion

Comfort upon insertion, as interpreted by the participant, was recorded on a questionnaire by the participant using a 10-point scale, with 1 being poor and 10 being excellent. Comfort upon insertion was assessed as a single, retrospective evaluation of 4-weeks' wear time.

Time frame: 4 weeks of wear

Population: Analysis conducted per protocol, with exclusions due to major protocol deviations as determined by masked review.

ArmMeasureValue (MEAN)Dispersion
Lotrafilcon BComfort Upon Insertion8.7 Units on a ScaleStandard Deviation 2
HabitualComfort Upon Insertion9.2 Units on a ScaleStandard Deviation 0.9

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026